Cargando…

Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells

Ferroptosis is a cell death pathway characterized by iron-dependent accumulation of reactive oxygen species (ROS) within the cell. The combination of siramesine, a lysosome disruptor, and lapatinib, a dual tyrosine kinase inhibitor, has been shown to synergistically induce cell death in breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Shumei, Dielschneider, Rebecca F., Henson, Elizabeth S., Xiao, Wenyan, Choquette, Tricia R., Blankstein, Anna R., Chen, Yongqiang, Gibson, Spencer B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565111/ https://www.ncbi.nlm.nih.gov/pubmed/28827805 http://dx.doi.org/10.1371/journal.pone.0182921

Ejemplares similares

Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
por: Ma, S, et al.
Publicado: (2016)

Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
por: Villalpando-Rodriguez, Gloria E., et al.
Publicado: (2019)

Prostate Cancer Cells Are Sensitive to Lysosomotropic Agent Siramesine through Generation Reactive Oxygen Species and in Combination with Tyrosine Kinase Inhibitors
por: Garcia, Emily A., et al.
Publicado: (2022)

Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes
por: Hafner Česen, M, et al.
Publicado: (2013)

Lysosomes as Oxidative Targets for Cancer Therapy
por: Dielschneider, Rebecca F., et al.
Publicado: (2017)

EGFR Family Members’ Regulation of Autophagy Is at a Crossroads of Cell Survival and Death in Cancer
por: Henson, Elizabeth, et al.
Publicado: (2017)

Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo
por: Jensen, Stine S., et al.
Publicado: (2017)

Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture.
por: Riegman, Michelle, et al.
Publicado: (2020)

A siramesine-loaded metal organic framework nanoplatform for overcoming multidrug resistance with efficient cancer cell targeting
por: Liu, Jiahui, et al.
Publicado: (2020)

Acute effects of the sigma-2 receptor agonist siramesine on lysosomal and extra-lysosomal proteolytic systems in lens epithelial cells
por: Jonhede, S., et al.
Publicado: (2010)

In Vitro Confirmation of Siramesine as a Novel Antifungal Agent with In Silico Lead Proposals of Structurally Related Antifungals
por: Vlainić, Josipa, et al.
Publicado: (2021)

Erb-b2 Receptor Tyrosine Kinase 2 (ERBB2) Promotes ATG12-Dependent Autophagy Contributing to Treatment Resistance of Breast Cancer Cells
por: Chen, Yongqiang, et al.
Publicado: (2021)

Tumor Suppressing Subtransferable Candidate 4 Expression Prevents Autophagy-Induced Cell Death Following Temozolomide Treatment in Glioblastoma Cells
por: Chen, Yongqiang, et al.
Publicado: (2022)

Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells
por: Huang, Huey-Lan, et al.
Publicado: (2011)

Effects of lapatinib on cell proliferation and apoptosis in NB4 cells
por: Liu, Lu, et al.
Publicado: (2018)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
por: Ye, Min, et al.
Publicado: (2021)

The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum
por: Klawonn, Anna M., et al.
Publicado: (2017)

Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib
por: Strickley, John D., et al.
Publicado: (2018)

Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis
por: Jia, Ji-Ning, et al.
Publicado: (2020)

Lapatinib-induced acute generalized exanthematous pustulosis
por: Lakshmi, Chembolli, et al.
Publicado: (2010)

Ferroptosis, autophagy, tumor and immunity
por: Xie, Yuyan, et al.
Publicado: (2023)

Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells
por: Tu, Chih-Yen, et al.
Publicado: (2014)

ALDH1-Mediated Autophagy Sensitizes Glioblastoma Cells to Ferroptosis
por: Wu, Yang, et al.
Publicado: (2022)

Cytotoxic T-Lymphocyte-Associated Protein 4 Haploinsufficiency-Associated Inflammation Can Occur Independently of T-Cell Hyperproliferation
por: Le Coz, Carole, et al.
Publicado: (2018)

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
por: Cristofanilli, Massimo, et al.
Publicado: (2012)

Corrigendum: Neuroprotective Effects of the Anti-Cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis
por: Jia, Ji-Ning, et al.
Publicado: (2022)

Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib
por: Gandhi, Mitul D, et al.
Publicado: (2014)

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
por: Chen, Yu-Jen, et al.
Publicado: (2016)

Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib
por: Geneste, A., et al.
Publicado: (2020)

Programmed Cell Death in Asthma: Apoptosis, Autophagy, Pyroptosis, Ferroptosis, and Necroptosis
por: Liu, Lu, et al.
Publicado: (2023)

Autophagy-dependent ferroptosis in kidney disease
por: Yang, Yuanting, et al.
Publicado: (2023)

The crosslinks between ferroptosis and autophagy in asthma
por: Lv, Xiaodi, et al.
Publicado: (2023)

Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells
por: Shu, Wenying, et al.
Publicado: (2023)

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience
por: Sutherland, S, et al.
Publicado: (2010)

Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
por: Chen, Yu-Jen, et al.
Publicado: (2014)

Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression
por: Guan, Mingxiu, et al.
Publicado: (2018)

Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib
por: Showalter, Loral E., et al.
Publicado: (2019)

Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell
por: Buss, Julieti Huch, et al.
Publicado: (2019)

HSP90 Inhibitor, 17-DMAG, Alone and in Combination with Lapatinib Attenuates Acquired Lapatinib-Resistance in ER-positive, HER2-Overexpressing Breast Cancer Cell Line
por: Lee, Hye Jin, et al.
Publicado: (2020)

Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling
por: Dielschneider, R F, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_urd9g5gj96fmgh70s3jfn3dkpr